# Nina Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nina-biotherapeutics

- Industry: Biotechnology
- Headquarters: Brisbane, US
- Total disclosed funding: $2.5M
- Latest round: Series B (Dec 3, 2013)
- Investors on record: 7

## About

Based in US and founded in 2012, Nina Biotherapeutics Inc. is a company that develops medical therapies to cure cachexia in cancer patients.

## Funding rounds

- Series B, Dec 3, 2013, $2.5M — Domain Associates, Kleiner Perkins, Amgen Ventures, EcoR1 Capital, Duff Ackerman & Goodrich Private Equity, Bristol-Myers Squibb Company, Alexandria Real Estate Equities

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B
- EcoR1 Capital (https://capitalatlas.ai/funds/ecor1-capital) — Series B
- Duff Ackerman & Goodrich Private Equity (https://capitalatlas.ai/funds/duff-ackerman-goodrich-private-equity) — Series B
- Bristol-Myers Squibb Company — Series B
- Alexandria Real Estate Equities — Series B